Age: 35.0
Sex: F
Vaccine: COVID19-2, FLUC4, COVID19-2, FLUC4
Symptoms: Blister, Erythema, Eyelid rash, Off label use, Oral mucosal eruption
Clinical narrative: Itchy; arm soreness; blisters; red; Rash is most prominent across my face, including my eyelids and inside my mouth. Secondarily on neck and wrists/inner arms; Rash is most prominent across my face, including my eyelids and inside my mouth.; Rash is most prominent across my face, including my eyelids and inside my mouth.; vaccine received same date: Flucelvax Quad; vaccine received same date: Flucelvax Quad; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Sep2022 at 17:00 as dose 4 (booster), single (Lot number: GJ2524) at the age of 35 years, in right arm for covid-19 immunisation; influenza vaccine inact sag 4v (FLUCELVAX QUAD), on 14Sep2022 as dose 1, single (Lot number: 942387), in right arm for immunisation. The patient's relevant medical history included: "Dermatographia" (unspecified if ongoing), notes: though nothing like this. Concomitant medication(s) included: CLARITIN [CLARITHROMYCIN]. Vaccination history included: Covid-19 vaccine (Dose: 01, Unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose: 02, Unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose: 03, Unknown manufacturer), for COVID-19 immunization.  The following information was reported: OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 14Sep2022, outcome "unknown" and all described as "vaccine received same date: Flucelvax Quad"; PRURITUS (non-serious) with onset 17Sep2022 at 10:00, outcome "not recovered", described as "Itchy"; EYELID RASH (non-serious), ORAL MUCOSAL ERUPTION (non-serious) all with onset 17Sep2022 at 10:00, outcome "not recovered" and all described as "Rash is most prominent across my face, including my eyelids and inside my mouth."; RASH (non-serious) with onset 17Sep2022 at 10:00, outcome "not recovered", described as "Rash is most prominent across my face, including my eyelids and inside my mouth. Secondarily on neck and wrists/inner arms"; PAIN IN EXTREMITY (non-serious) with onset 17Sep2022 at 10:00, outcome "not recovered", described as "arm soreness"; BLISTER (non-serious) with onset 17Sep2022 at 10:00, outcome "not recovered", described as "blisters"; ERYTHEMA (non-serious) with onset 17Sep2022 at 10:00, outcome "not recovered", described as "red". The events "itchy", "arm soreness", "blisters", "red", "rash is most prominent across my face, including my eyelids and inside my mouth. secondarily on neck and wrists/inner arms" and "rash is most prominent across my face, including my eyelids and inside my mouth." required physician office visit. Therapeutic measures were taken as a result of pruritus, pain in extremity, blister, erythema, rash, eyelid rash, oral mucosal eruption.  Additional information: Facility type vaccine was Pharmacy or Drug Store. The patient did not have covid prior vaccination. The patient did not test for covid post vaccination. The patient did not have known allergies. The patient did not receive any other vaccine in four weeks. No issues immediately after vaccination, except a normal level of arm soreness. Woke up Saturday morning with a heinous rash. Itchy, red, raised bumps with some progressing into blisters filled with clear fluid. Rash was most prominent across her face, including her eyelids and inside her mouth. Secondarily on neck and wrists/inner arms. A few isolated spots on forearms, torso, and legs. All the events were treated with topical steroid ointment.